CYP7A1 and metabolic disease: Li et al. demonstrated that the induction of hepatic CYP7A1 had the potential to prevent obesity, fatty liver, and insulin resistance induced by a high-fat diet, thereby presenting a promising therapeutic alternative for metabolic disorders in humans [36].